Treating Major Depression With Yoga Mono-therapy

Recruiting now · Not applicable

Conditions studied: Depression Mild, Depression Moderate

In brief

The goal of this single-center, single-blind, randomized, controlled, parallel group, interventional trial is to evaluate antidepressant efficacy of yoga monotherapy of 12-weeks duration in 180 adults meeting diagnostic criteria for mild-to-moderate major depression at the Zuckerberg San Francisco General Hospital. Researchers will compare the yoga interventions to an education control intervention on holistic healthcare.

Key facts

Study ID

NCT06091527

Run by

University of California, San Francisco

People needed

180

Starts

2024-10-25

Expected to finish

2026-06-01

Last updated by the study team

2025-11-06

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• 18 years of age or older
• Able to give voluntary, informed consent
• English-speaking
• Diagnosis of clinical depression

You may not qualify if…

• Current use of antidepressant medication
• Current engagement in psychotherapy
• Current pregnancy
• Significant medical issues interfering with yoga practice

Where it is running

• Zuckerberg San Francisco General Hospital — San Francisco, California, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.